NCT00003493View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1998

Study Completion Date

April 30, 2004

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

dexamethasone

DRUG

pegylated liposomal doxorubicin hydrochloride

DRUG

vincristine sulfate

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00003493 - Combination Chemotherapy in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter